PMC:7341464 / 1921-2280 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":74,"end":77},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0001014"},{"id":"A27","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0011996"}],"text":"At time of submission, 167 patients have registered for the study and 148 CML patients (median age, 57.5 years; range 26–82 years; 48% males) and 123 housemates (median age 60 years, range 24–88 years) were included, with enrolment still ongoing. The baseline characteristics are presented in Supplementary Table 1. The majority (88.4%) had taken TKI therapy."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T16","span":{"begin":70,"end":73},"obj":"http://purl.obolibrary.org/obo/CLO_0001079"},{"id":"T17","span":{"begin":131,"end":133},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T18","span":{"begin":135,"end":140},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T19","span":{"begin":135,"end":140},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"}],"text":"At time of submission, 167 patients have registered for the study and 148 CML patients (median age, 57.5 years; range 26–82 years; 48% males) and 123 housemates (median age 60 years, range 24–88 years) were included, with enrolment still ongoing. The baseline characteristics are presented in Supplementary Table 1. The majority (88.4%) had taken TKI therapy."}

{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":246},"obj":"Sentence"},{"id":"T16","span":{"begin":247,"end":315},"obj":"Sentence"},{"id":"T17","span":{"begin":316,"end":359},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"At time of submission, 167 patients have registered for the study and 148 CML patients (median age, 57.5 years; range 26–82 years; 48% males) and 123 housemates (median age 60 years, range 24–88 years) were included, with enrolment still ongoing. The baseline characteristics are presented in Supplementary Table 1. The majority (88.4%) had taken TKI therapy."}

{"project":"LitCovid-PubTator","denotations":[{"id":"59","span":{"begin":27,"end":35},"obj":"Species"},{"id":"60","span":{"begin":78,"end":86},"obj":"Species"},{"id":"61","span":{"begin":74,"end":77},"obj":"Disease"}],"attributes":[{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Tax:9606"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"Tax:9606"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D015464"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"At time of submission, 167 patients have registered for the study and 148 CML patients (median age, 57.5 years; range 26–82 years; 48% males) and 123 housemates (median age 60 years, range 24–88 years) were included, with enrolment still ongoing. The baseline characteristics are presented in Supplementary Table 1. The majority (88.4%) had taken TKI therapy."}